Name | Enokizumab |
---|
Description | Enokizumab (MEDI-528) is a monoclonal antibody targeting to interleukin (IL)-9. IL-9 regulates the development of airway inflammation, mucus production, airway hyperresponsiveness, and airway fibrosis largely by increasing mast cell numbers and activity in the airways[1]. |
---|---|
Related Catalog | |
Target |
IL-9[1] |
No Any Chemical & Physical Properties |